Semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with extended half-life properties, widely studied in metabolic and appetite regulation research.
What This Compound Is
Semaglutide is a long-acting GLP-1 receptor agonist with structural modifications that extend its half-life. This peptide analogue is extensively studied in metabolic research for its effects on glucose regulation and appetite control. Researchers use it to investigate GLP-1 receptor signaling pathways and their role in metabolic homeostasis.
Research Interest
Scientific studies on Semaglutide focus on GLP-1 receptor activation and its downstream effects on metabolic processes. Research examines its influence on insulin secretion, glucagon suppression, gastric motility, and central nervous system appetite regulation. Studies also investigate its effects on cardiovascular parameters, inflammation markers, and cellular stress responses in laboratory settings.
Educational Disclaimer
For laboratory research purposes only. Not for human consumption or clinical use. This product is intended solely for in-vitro research and educational applications.
Available Formats
Related Research Compounds
Explore similar peptides and compounds that researchers often study together